These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
930 related articles for article (PubMed ID: 23899992)
1. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis. Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992 [TBL] [Abstract][Full Text] [Related]
2. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811 [TBL] [Abstract][Full Text] [Related]
3. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599 [TBL] [Abstract][Full Text] [Related]
4. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice. Kuerten S; Gruppe TL; Laurentius LM; Kirch C; Tary-Lehmann M; Lehmann PV; Addicks K APMIS; 2011 Jun; 119(6):336-46. PubMed ID: 21569091 [TBL] [Abstract][Full Text] [Related]
5. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis. Soellner IA; Rabe J; Mauri V; Kaufmann J; Addicks K; Kuerten S Clin Immunol; 2013 Dec; 149(3):519-29. PubMed ID: 24239839 [TBL] [Abstract][Full Text] [Related]
6. The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis. Gruppe TL; Recks MS; Addicks K; Kuerten S Histol Histopathol; 2012 Sep; 27(9):1163-74. PubMed ID: 22806903 [TBL] [Abstract][Full Text] [Related]
7. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis. Kuerten S; Angelov DN Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137 [TBL] [Abstract][Full Text] [Related]
8. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Herrero-Herranz E; Pardo LA; Gold R; Linker RA Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527 [TBL] [Abstract][Full Text] [Related]
9. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response. Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967 [TBL] [Abstract][Full Text] [Related]
10. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Zheng H; Zhang H; Liu F; Qi Y; Jiang H Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208 [TBL] [Abstract][Full Text] [Related]
11. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice. Bannerman PG; Hahn A J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638 [TBL] [Abstract][Full Text] [Related]
12. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. Kuerten S; Javeri S; Tary-Lehmann M; Lehmann PV; Angelov DN Clin Immunol; 2008 Nov; 129(2):256-67. PubMed ID: 18722816 [TBL] [Abstract][Full Text] [Related]
13. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis. Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039 [TBL] [Abstract][Full Text] [Related]
14. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide. Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262 [TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383 [TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Kuerten S; Schickel A; Kerkloh C; Recks MS; Addicks K; Ruddle NH; Lehmann PV Acta Neuropathol; 2012 Dec; 124(6):861-73. PubMed ID: 22842876 [TBL] [Abstract][Full Text] [Related]
17. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant. Jagessar SA; Heijmans N; Blezer EL; Bauer J; Weissert R; 't Hart BA J Neuroinflammation; 2015 Sep; 12():169. PubMed ID: 26377397 [TBL] [Abstract][Full Text] [Related]
18. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair. Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177 [TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]